COPD
Chronic Obstructive Pulmonary Disorder (COPD)
CHEST’s resources on chronic obstructive pulmonary disorder (COPD) help guide clinicians in providing the highest-quality care for patients with this condition. Access original research from the journal CHEST®, webinars, CHEST Physician® articles, CHEST SEEK™ Education, and educational courses and events.
CHEST Journal Highlights
By: Kerry Day, PhD; Kristoffer Ostridge, PhD; Joy Conway, PhD; et al
April 2021 Issue
In this article, the authors found that measures of small airways dysfunction were associated strongly with neutrophilic inflammation in the small airways of patients with frequent COPD exacerbations.
Read the related editorial: The “Silent Zone” Screams Again: Identifying COPD Patients Most at Risk »
By: Zafar Zafari, PhD; Shukai Li, BSc; Michelle N. Eakin, PhD; Martine Bellanger, PhD; and Robert M. Reed, MD
April 2021 Issue
COPD is a leading cause of mortality in the US, with a substantial societal health and economic burden. The goal of this study was to model the 20-year health and economic burden of COPD in the United States.
By: Gul Jana Saeed, MD; Javier Valero-Elizondo, MD, MPH; Reed Mszar, MPH; et al
April 2021 Issue
Influenza-related infections are among the main causes of COPD exacerbations, hospitalizations, and mortality, all of which have been proven to be diminished with influenza vaccination. This research letter aimed to measure influenza vaccination uptake in adults with COPD in the United States and explore potential sociodemographic disparities in access to influenza vaccination.
VISUAL ABSTRACT
Medication Discontinuation in Adults With COPD Discharged From the Hospital
What is the risk of unintentional medication discontinuation following hospital discharge in older adults with COPD?
STUDY DESIGN
- Retrospective population-based cohort study included adults with COPD aged ≥66 years who had filled prescriptions for a long-acting muscarinic antagonist (LAMA) or long-acting beta-agonist and inhaled corticosteroid (LABA-ICS) continuously for 1 year or more
RESULTS
- More than 27,613 hospitalization discharges, and medications were discontinued 1,466 times
- Among 78,953 patients with COPD, those hospitalized had a higher risk of having medications being discontinued than those who remained in the community
| |
RATES OF DISCONTINUATION |
| |
LAMA |
LABA-ICS |
| Hospitalized |
5.2% |
5.5% |
| Non-Hospitalized |
3.3% |
3.1% |
| Adjusted Risk Ratios |
1.50 (1.34, 1.67) |
1.62 (1.39, 1.90) |
In a study of highly adherent patients with COPD, hospitalization was associated with an increased risk of long-acting inhaler discontinuation.
DOWNLOAD THE VISUAL ABSTRACT
Read the related article: Medication Discontinuation in Adults With COPD Discharged From the Hospital: A Population-Based Cohort Study »
CHEST Journal | Access the journal's full collection of COPD research. Read the journal »
CHEST Player Hub
COPDetective
Are you ready to solve a mystery? Become a detective of pulmonology while analyzing physician and patient dialogue and identifying the best disease management for patients with COPD. Learn about the underrecognized and underreported symptoms, the link between lung function and exacerbation, the ideal pharmacological and nonpharmacological choices, and treatment for comorbid conditions.
Start playing now »
Supporter information can be found in the Player Hub.
CHEST Clinical Perspectives™
SPONSORED CONTENT
This exclusive report presents findings on which traits community-based pulmonologists use to predict the risk and severity of COPD exacerbations, particularly in patients who have never had any exacerbations.
A non-promotional, non-CME educational program brought to you by CHEST, in collaboration with GlaxoSmithKline.
e-Learning Courses
Stay on the cutting edge of patient care and earn CME credit with COPD learning opportunities available exclusively through CHEST.
ACCREDITED CONTENT
Chronic Obstructive Pulmonary Disease Spotlight
Learn about clinical uncertainties in treatment of COPD, new technologies for treatment, emerging care modalities, and the impact of gender, age, and obesity on obstructive lung disease, including COPD.
CME/MOC Available: 8.0 CME credits/MOC points
ACCREDITED CONTENT
Pulmonary Update and Literature Review
Leading experts review the published literature and provide updates on treatment options in eight important pulmonary topics, including COPD.
CME/MOC Available: 8.0 CME credits/MOC points
ACCREDITED CONTENT
COPD Virtual Patient Tour
Explore a patient case and apply your COPD knowledge to choose diagnostic and treatment strategies.
CME/MOC Available: 1.0 CME credit/MOC point
CHEST E-LEARNING LIBRARY | Customize a learning plan specific to your needs. SUBSCRIBE NOW »
CHEST SEEK™ Education
Written and peer reviewed by renowned experts in the pulmonary, critical care, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought processes; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.
A patient is discharged from the hospital after management of an acute exacerbation of COPD (AECOPD). In this setting, which risk factors are most predictive of this patient being readmitted to hospital?
A. Increasing age and male sex
B. Depression and prior hospitalization for AECOPD in the last year
C. Current smoking and comorbid conditions such as chronic heart failure
D. Anxiety and hyponatremia during hospitalization
Submit your email address for the correct answer
CHEST SEEK LIBRARY | Access hundreds of pulmonary, critical care, and sleep medicine questions. PURCHASE NOW »
Nebulization in the COVID-19 Era
New CHEST clinician resources can help you visualize the viral transmission of respiratory pathogens and understand the reality behind common myths regarding whether nebulizers are a source of infection among bedside health care workers.
Watch a video review of the literature regarding COVID-19 and nebulizer therapy.
COPD News From CHEST Physician®
There appears to be a growing interest in patients with hypercapnic COPD, driven by a focus on reducing COPD hospitalizations, increasing recognition of sleep-disordered breathing, and making progress in potential therapeutic strategies.
Patients with COPD may benefit from stepped-up treatment of short-term disease progression with triple therapy to stave off longer-term exacerbations and all-cause mortality.
The list of medical comorbidities associated with high risk for severe COVID-19 now includes moderate to severe asthma, diabetes, and substance use disorders, according to the Centers for Disease Control and Prevention.
Older adults with COPD who began using synthetic cannabinoids showed a 64% increase in all-cause mortality, compared with nonusers, findings from a large study have shown.
READ MORE FROM CHEST PHYSICIAN
COPD Webinar
SPONSORED CONTENT
State of Practice: Community-Based Pulmonologists and COPD Exacerbation
Drs. Hassan Bencheqroun, Brian Carlin, Chitra Lal, and Deborah Jo Levine join moderator Mark Rudzinski to discuss research on how community-based pulmonologists evaluate pulmonary, extrapulmonary, and behavioral traits in patients with COPD, as well as how they determine which traits are considered most predictive of a COPD exacerbation.
A non-promotional, non-CME educational program brought to you by CHEST, in collaboration with GlaxoSmithKline.
ACCREDITED CONTENT
COPD Sessions at CHEST 2020
Couldn't attend CHEST Annual Meeting 2020? We have the next best thing! Gain access to all of the recorded sessions from our meeting with this unique collection that includes hours’ worth of the latest presentations from some of the top clinicians and researchers in chest medicine, including:
- Obstructive Lung Diseases in Women – Is There a Difference?
- Noninvasive Ventilation in Ambulatory COPD
- Phenotyping and Management of COPD
- New Insights Into COPD and Its Complications
PURCHASE NOW
Join the Community
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities. Join now »